Efficient Enrichment of Gene-Modified Primary T Cells via CCR5-Targeted Integration of Mutant Dihydrofolate Reductase
Open Access
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 9, 347-357
Abstract
No abstract availableKeywords
Funding Information
- Core Center of Excellence in Hematology
- Fred Hutchinson Cancer Center
- Hutch United
- NIH
- National Heart, Lung, and Blood Institute (R01 HL116217, U19 HL129902)
- Jose Carreras/E. Donnall Thomas Endowed Chair for Cancer Research
- Fred Hutch Endowed Chair for Cell and Gene Therapy
This publication has 50 references indexed in Scilit:
- Engineering Human T Cells for Resistance to Methotrexate and Mycophenolate Mofetil as an In Vivo Cell Selection StrategyPLOS ONE, 2013
- Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphomaLeukemia & Lymphoma, 2012
- Extended Survival of Glioblastoma Patients After Chemoprotective HSC Gene TherapyScience Translational Medicine, 2012
- Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivoNature Biotechnology, 2010
- Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primatesJournal of Clinical Investigation, 2010
- Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vectorGene Therapy, 2010
- In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductaseGene Therapy, 2009
- Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleasesNature Biotechnology, 2008
- Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primatesJournal of Clinical Investigation, 2008
- Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vectorNature Biotechnology, 2004